I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Schuhler, Carole
11
results:
Search for persons
X
Format
Online (11)
Mediatypes
Articles (Online) (4)
OpenAccess-fulltext (7)
Languages
english (8)
french (2)
Sorted by: Relevance
Sorted by: Year
?
1
LTA4H inhibitor LYS006: Clinical PK/PD and safety in a rand..:
Loesche, Christian
;
Picard, Damien
;
Van Hoorick, Benjamin
...
Clinical and Translational Science. 17 (2024) 2 - p. , 2024
Link:
https://doi.org/10.1111/..
?
2
Novel Bruton's tyrosine kinase inhibitor remibrutinib: Asse..:
Schiller, Hilmar
;
Huth, Felix
;
Schuhler, Carole
...
European Journal of Pharmaceutical Sciences. 172 (2022) - p. 106155 , 2022
Link:
https://doi.org/10.1016/..
?
3
Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug..:
Huth, Felix
;
Schiller, Hilmar
;
Jin, Yi
...
Clinical and Translational Science. 15 (2021) 1 - p. 118-129 , 2021
Link:
https://doi.org/10.1111/..
?
4
Remibrutinib (LOU064): A selective potent oral BTK inhibito..:
Kaul, Martin
;
End, Peter
;
Cabanski, Maciej
...
Clinical and Translational Science. 14 (2021) 5 - p. 1756-1768 , 2021
Link:
https://doi.org/10.1111/..
?
5
Remibrutinib (LOU064): A selective potent oral BTK inhibito..:
Kaul, Martin
;
End, Peter
;
Cabanski, Maciej
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504815/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
6
Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug..:
Huth, Felix
;
Schiller, Hilmar
;
Jin, Yi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742645/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
7
Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug..:
Felix Huth
;
Hilmar Schiller
;
Yi Jin
...
https://doi.org/10.1111/cts.13126. , 2022
Link:
https://doi.org/10.1111/..
?
8
Remibrutinib (LOU064): A selective potent oral BTK inhibito..:
Martin Kaul
;
Peter End
;
Maciej Cabanski
...
https://doi.org/10.1111/cts.13005. , 2021
Link:
https://doi.org/10.1111/..
?
9
The GRAVITY+ Project: Towards All-sky, Faint-Science, High-..:
Collaboration, GRAVITY+
;
:
;
Abuter, Roberto
...
http://arxiv.org/abs/2301.08071. , 2023
Link:
http://arxiv.org/abs/230..
?
10
Caractérisation par PIV de la couche limite d'un jet chaud ..:
Schuhler, Eliot
;
Lecordier, Bertrand
;
Yon, Jérome
..
hal-02097657. , 2018
Link:
https://hal.science/hal-..
?
11
Caractérisation par PIV de la couche limite d'un jet chaud ..:
Schuhler, Eliot
;
Lecordier, Bertrand
;
Yon, Jérome
..
hal-02097657. , 2018
Link:
https://hal.archives-ouv..
1-11